Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet BUPRENORFINA ALKALOID 2mg sublingual tablets
- Product code:
- W58840001
- Quantity:
- 7
- Indicated for:
- severe pain; opioid dependence
- Route of administration:
- sublingual
- Substance:
- buprenorphine (opioid analgesic)
- ATC
- N07BC01 — Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Dependence / abuse
This medicine may cause dependence or be misused.
Respiratory depression
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol
Avoid alcohol during treatment.
Major drug interactions
This medicine may have important interactions with other medicines.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Elderly warning
Older people may have an increased risk of side effects.
Withdrawal / do not stop abruptly
Do not stop treatment abruptly without medical advice.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Buprenorphine is an opioid analgesic used for the treatment of moderate to severe pain and for managing opioid dependence. It is a partial agonist of mu-opioid receptors and an antagonist of kappa-opioid receptors, providing strong analgesic effects with a lower risk of respiratory depression compared to other opioids.
The medication is available in the form of sublingual tablets, transdermal patches, or injections, and the dosage is adjusted based on the severity of pain or the patient's needs in opioid dependence treatment.
Common side effects include nausea, constipation, dizziness, drowsiness, and excessive sweating. In rare cases, more severe adverse effects such as severe respiratory depression or allergic reactions may occur.
Buprenorphine is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, the use of this medication requires careful medical supervision to prevent abuse, dependence, or other complications associated with opioids.
The medication is available in the form of sublingual tablets, transdermal patches, or injections, and the dosage is adjusted based on the severity of pain or the patient's needs in opioid dependence treatment.
Common side effects include nausea, constipation, dizziness, drowsiness, and excessive sweating. In rare cases, more severe adverse effects such as severe respiratory depression or allergic reactions may occur.
Buprenorphine is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, the use of this medication requires careful medical supervision to prevent abuse, dependence, or other complications associated with opioids.
General data about BUPRENORFINA ALKALOID 2mg
- Substance:
- buprenorphine
- Date of latest medicines list:
- 01-03-2026
- Product code:
- W58840001
- Concentration:
- 2mg
- Pharmaceutical form:
- sublingual tablets
- Quantity:
- 7
- Product type:
- Generic medicine
- Prescription status:
- TAB3 — Medicines dispensed with a special medical prescription for psychotropic substances, green in color.
Pharmaceutical forms available for buprenorphine
Concentrations available for buprenorphine
- 0.4mg
- 2mg
- 35mcg/h
- 52.5mcg/h
- 70mcg/h
- 74.2mg
- 8mg